More Articles Back to Article
Indian vaccine manufacturer predicts lengthy shortage
Adar Poonawalla, chief executive of India's Serum Institute, expects vaccines to be in short supply for several months as Indian health officials grapple with a rise in new cases. Pfizer is asking the Indian government to expedite approval of its vaccine developed with BioNTech. Reuters (5/3)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!